IL6 and Shock: Patients were not eligible if they exhibited respiratory failure requiring invasive mechanical ventilation, septic shock, or multiple organ dysfunction at enrollment or received cytokine inhibitory therapy (targeting IL-6, IL-6R, IL-1, or Janus kinase).